- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormono Therapy in Russian Federation
Total 608 results
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia
-
AstraZenecaCompletedDiabetesUnited States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Spain, Switzerland, Argentina, Finland, Hungary, Russian Federation, Slovenia, Slovakia
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
BayerCompletedDiabetic RetinopathyKorea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Taiwan, Ukraine, Morocco, Belgium, Czechi...
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Russian Federation, United Kingdom, France, Ukraine
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedThyroid CancerUnited States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Russian Federation, United Kingdom, Canada, France, Netherlands, Belgium, Germany, Slovenia
-
Threshold PharmaceuticalsPPDCompletedPancreatic CancerUnited States, Brazil, Ukraine, India, Russian Federation, Romania, Hungary, Mexico, Argentina, Bulgaria, Czech Republic
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Bulgaria, Russian Federation, United Kingdom, Hungary, Romania, Finland, Canada, Austria, Germany, Netherlands, Slovakia, Spain
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Bulgaria, Czechia, Hungary, Poland, Russian Federation
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
AstraZenecaCompletedZollinger-Ellison SyndromeUnited States, France
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCroatia, United States, Bulgaria, Czech Republic, Poland, Russian Federation, Belarus, Estonia, Germany, Hungary, Latvia, Lithuania, Romania, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2United States, Belgium, Bulgaria, Colombia, Czech Republic, Finland, France, Germany, Guatemala, Mexico, Peru, Russian Federation, Spain, Ukraine
-
PfizerCompletedNSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMAUnited States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Slovakia, Spain, France, Hungary, Mexico, Russian Federation, Turkey, Czechia, Greece, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Germany, Puerto Rico, United Kingdom, Spain, Canada, Brazil, Korea, Republic of, India, Israel, Russian Federation, South Africa
-
Mannkind CorporationCompletedType 1 Diabetes | Type 2 DiabetesUnited States, Brazil, Canada, Russian Federation
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Italy, Poland, Russian Federation, United Kingdom, Canada, Denmark, Sweden, Austria, Belgium, Spain, Ireland, Norway, Serbia, Finland, Portugal, Ukraine
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian CancerUnited States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2United States, Brazil, Spain, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, Ukraine, Czech Republic
-
Boehringer IngelheimCompletedHypertension | Diabetic NephropathiesSpain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Mexico, Brazil, Puerto Rico, Japan, Argentina, Russian Federation
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
AstraZenecaMedImmune LLCCompletedDiabetes Mellitus, Type 2Germany, United States, Canada, Russian Federation, Slovakia, Czechia, Bulgaria, Mexico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico